PPARG and fatty liver disease: Discrepant findings have been reported regarding the consequences of increased PPARG activity in liver, ranging from the promotion of hepatic steatosis through the upregulation of genes involved in lipid uptake and storage, to the prevention of hepatic steatosis and fibrosis, possibly by sequestering fatty acids in adipose tissue and preventing hepatic stellate cell activation (reviewed in [82]).